The RasGRP3 expression increases in SLE B lymphocytes and PBMCs, which results in enhanced activation of B lymphocytes through ERK1/2 and AKT signaling pathways and the overproduction of inflammatory interleukins such as TNF-α and IL-6 (122). Here, MAPK3 is linked to systemic lupus erythematosus.